Keywords: promising, ph, iii, results, biogen, amevive, reported

Promising Ph III results for Biogen's Amevive

Article | 13 June 2001

Print This

Biogen has reported promising results from a Phase III clinical trial ofits psoriasis drug Amevive (alefacept), in which the drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in